What are the research recommendations for blood pressure management in kidney transplant recipients (CKD G1T G5T)?
Research recommendations for blood pressure management in kidney transplant recipients (CKD G1T G5T) include conducting studies examining the addition of endothelin blockers or GLP-1 receptor agonists to concomitant RASi monotherapy for potential kidney benefits in the advanced CKD (G4 G5) population and the nonproteinuric CKD populations; examining the benefits of dual versus monotherapy on major kidney outcomes in people with CKD without diabetes and severely increased proteinuria (e.g., >2 3 g/d); and conducting research to identify individuals who will benefit or experience harm from these combinations in all CKD populations.